FDA Releases Guidance Document for Chemistry, Manufacturing, and Controls Information for Therapeutic Recombinant DNA-Derived Products and Monoclonal Antibody Products

Summary

The Food and Drug Administration (FDA) has made available a guidance document to help manufacturers prepare the necessary chemistry, manufacturing, and controls information for marketing applications of certain therapeutic recombinant DNA-derived products and monoclonal antibody products intended for in vivo use.